Summary
Man has evolved sophisticated defence mechanisms over millions of years to combat insertion of foreign DNA into his cells. However, gene therapy carries huge potential for the treatment of cancer. The challenge is therefore to translate our scien-tific knowledge into a clinical reality.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abel-Wahab Z., Weltz C., Hester D., Pickett N., Vervaert C., Barber JH.R., Jolly D., and Seigler H.F., 1997. A Phase I clinical trial of immunotherapy with interferon-y gene-modified autologous melanoma ceils. Cancer 80:401–412.
Belli F., Arienti F., and Sule-Suso J., 1997. Active immunisation of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: Evaluation of efficacy and tolerability. Cancer Immunol. Immunother 44:197–203.
Cai D.W., Mukhopadhyay T., Lui Y., Fujiwara T., and Roth J.A., 1993. Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer. Hum Gene Ther. 4:617–624.
Culver K.W., Ram Z., Wallbridge S., Ishi H., Oldfield E.H., and Blaese R.M., 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumours. Science 256:1550–1552.
Fidler I.J., and Ellis L.M., 1994. The implications of angiogenesis for the biology and therapy of cancer metastases. Cell 79:185–188.
Freeman S.M., Abboud C.N., Whartenby K.A., Packman C.H., Koeplin D.S., Moolten F.L., and Abraham G.N., 1993. The “Bystander Effect”: Tumour regression when a fraction of the tumour mass is genetically modified. Cancer Res. 53:5274–5283.
Fujiwara T., Grimm E.A., Mukhopadhyay T., Zhang W.W., Owen-Schaub L.B., and Roth J.A., 1994. Induction chemosensitivity in human lung cancer cells in vivo by adenoviral-mediated transfer of the wildtype p53 gene. Cancer Res. 54:2287–2291.
Grimm E.A., Crump W.L., Durett A., Hester J.P., Lagoo-Deenadalavan S., and Owen-Schaub L.B., 1998. TGF-beta inhibits the in vitro induction of lymphokine-activated killing activity. Cancer Immumol. Immunother 27:53–58.
Hollestein M., Sidransky D., Vogelstein B., and Harris C.C., 1991, P35 mutations in human cancers Science 253:49–53.
Hui K.M., Ang P.T., Huang L., and Tay S.K., 1997. Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes. Gene Ther. 4:783–790.
Kong H-L., and Crystal R.G., 1998. J. Natl. Cancer Inst. 90:273–286.
Roth J.A., and Cristiano R.J., 1997. Gene therapy for cancer: What have we done and where are we going? J. Natl. Cancer Inst. 89, No.l 21–39.
Takahashi T., Carbone D., Takahashi T., Nau M.N., Hida T., Linnoila I., Ueda R., and Minnay J.D., 1992. Wild type but not mutant p53 suppresses growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res. 52:2340–2343.
Tjuvajev J.G., Finn R., Watanabe K., Joshi R., Oku T., Kennedy J., Beattie B., Koutcher J., Larson S., and Blasberg R.G., 1996. Non invasive imaging of herpes virus thymidine kinase gene transer and expression: A potential method for monitoring clinical gene therapy. Cancer Research 56:4087–4095.
Wan Y.H., Bramson J., Carter R., Grapham P., and Gauldie J., 1997. Dendritic cells transduced with an adenoviral vector encoding a model tumour-associated antigen for tumour vaccination. Hum Gene Ther. 8:1355–1363.
Zhu N., Liggitt D., Liu Y, and Debs R., 1993. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261:209–211.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Cleator, S.J., Price, P. (2002). Management Problems in Oncology. In: Habib, N.A. (eds) Cancer Gene Therapy. Advances in Experimental Medicine and Biology, vol 465. Springer, New York, NY. https://doi.org/10.1007/0-306-46817-4_1
Download citation
DOI: https://doi.org/10.1007/0-306-46817-4_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46191-0
Online ISBN: 978-0-306-46817-9
eBook Packages: Springer Book Archive